Value of stimulated pre-ablation thyroglobulin as a prognostic marker in patients with differentiated thyroid carcinoma treated with radioiodine
Article in Endocrine (March 2022)
The most recent citing publications are shown below. View all 2 publications that cite this research output on Dimensions.
Recombinant Human Thyroid-Stimulating Hormone-Aided Remnant Ablation Achieves a Response to Treatment Comparable to That with Thyroid Hormone Withdrawal in Patients with Clinically Relevant Lymph Node Metastases
Article in European Thyroid Journal (December 2014)